DDInter731 DDInter1180
Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Fesoterodine {u} (Compound) resembles {v} (Compound) Tolterodine
Fesoterodine {u} (Compound) binds {v} (Gene) CYP2D6
Fesoterodine {u} (Compound) causes {v} (Side Effect) Hypersensitivity
Fesoterodine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Brompheniramine
Fesoterodine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Lumacaftor
Fesoterodine {u} may lead to a major life threatening interaction when taken with {v} Idelalisib
Fesoterodine {u} may lead to a major life threatening interaction when taken with {v} Clarithromycin
Fesoterodine (Compound) resembles Tolterodine (Compound)
Fesoterodine (Compound) binds CYP2D6 (Gene)
Fesoterodine (Compound) causes Hypersensitivity (Side Effect)
Fesoterodine may cause a moderate interaction that could exacerbate diseases when taken with Brompheniramine
Fesoterodine may cause a moderate interaction that could exacerbate diseases when taken with Lumacaftor
Fesoterodine may lead to a major life threatening interaction when taken with Idelalisib
Fesoterodine may lead to a major life threatening interaction when taken with Clarithromycin